Madrigal Pharmaceuticals (MDGL) Analyst & Key Data

Analyst Consensus

Buy20 analysts

Buy

Updated Sep 12, 2026

Total Analysts20

Buy

22

Hold

2

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score5.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$534.49

Median Target+25.15%

$668.90

Potential upside vs current price

DCF Value+359.90%

$2,458.13

Potential upside vs current price

Current Stock Price

$534.49

Median Target+25.15%

$668.90

Potential upside vs current price

DCF Value+359.90%

$2,458.13

Potential upside vs current price

Analyst Consensus

Buy20 analysts

Buy

Updated Sep 12, 2026

Total Analysts20

Buy

22

Hold

2

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score5.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$534.49

Median Target+25.15%

$668.90

Potential upside vs current price

DCF Value+359.90%

$2,458.13

Potential upside vs current price

Current Stock Price

$534.49

Median Target+25.15%

$668.90

Potential upside vs current price

DCF Value+359.90%

$2,458.13

Potential upside vs current price

Madrigal Pharmaceuticals, Inc.